ImStar Therapeutics is a biotechnology company developing a breakthrough new approach to treating Amyotrophic Lateral Sclerosis (ALS), or Lou Gehrig's Disease. By exploiting an important new biological target underlying the disease, they hope to make great strides in treating ALS and other related neurodegenerative disorders such as Dementia, Alzheimer's Disease and Parkinson's Disease.
Company Details
- Employees
- 3
- Founded
- -
- Address
- 1285 West Broadway, Suite 600,canada
- in****@****rtx.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.imstartx.com
- Keywords
- Biotechnology, Neuroscience, Neurology, ALS.
- HQ
- Vancouver, BC
Imstar Therapeutics Inc. Questions
Imstar Therapeutics Inc.'s website is http://www.imstartx.com
Imstar Therapeutics Inc.'s LinkedIn profile is https://ca.linkedin.com/company/imstar-therapeutics-inc-
Imstar Therapeutics Inc. has
3 employees.
View email and phone details for 3
employees at Imstar Therapeutics Inc..
Imstar Therapeutics Inc.'s industry is
Biotechnology Research
Imstar Therapeutics Inc.'s top competitors are
Vog Calgary App Developer,
Gfr90,
Pawsperity Biotechnologies Inc.,
Universal Ibogaine Inc. (Tsxv: Ibo),
The Verse,
Zalicus,
Eezepro,
Eno,
Telemed Diagnostic Management,
Syngli Inc. (Neurecall Inc.).
Imstar Therapeutics Inc.'s support email address is info@imstartx.com
Imstar Therapeutics Inc.'s categories are Biotechnology Research
Imstar Therapeutics Inc.'s founding year is 2012
